These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20701625)

  • 1. Lipid assessment, metabolic syndrome and coronary heart disease risk.
    Arsenault BJ; Després JP; Stroes ES; Wareham NJ; Kastelein JJ; Khaw KT; Boekholdt SM
    Eur J Clin Invest; 2010 Dec; 40(12):1081-93. PubMed ID: 20701625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.
    Arsenault BJ; Rana JS; Stroes ES; Després JP; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
    J Am Coll Cardiol; 2009 Dec; 55(1):35-41. PubMed ID: 20117361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study.
    van Capelleveen JC; Bochem AE; Boekholdt SM; Mora S; Hoogeveen RC; Ballantyne CM; Ridker PM; Sun W; Barter PJ; Tall AR; Zwinderman AH; Kastelein JJP; Wareham NJ; Khaw KT; Hovingh GK
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28775061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age, Sex, and Cardiovascular Risk Attributable to Lipoprotein Cholesterol Among Chinese Individuals with Coronary Artery Disease: A Case-Control Study.
    Wu TT; Zheng YY; Yang YN; Li XM; Ma YT; Xie X
    Metab Syndr Relat Disord; 2019 May; 17(4):223-231. PubMed ID: 30720383
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
    Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB
    Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
    Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
    JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity.
    Ying X; Qian Y; Jiang Y; Jiang Z; Song Z; Zhao C
    Acta Diabetol; 2012 Dec; 49(6):465-72. PubMed ID: 22965469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particles and corrected particles of LDL and non-HDL are stronger predicters of coronary lesion in postmenopausal women.
    Li C; Chen J; Wei S; Zhang M; Chu Y; Meng F; Wang J; Tang J; Luo J; Yang Y; Niu X; Cai W
    BMC Cardiovasc Disord; 2021 Aug; 21(1):369. PubMed ID: 34340681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
    Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
    Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-HDL cholesterol vs. apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population study.
    Sondermeijer BM; Rana JS; Arsenault BJ; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
    Eur J Clin Invest; 2013 Oct; 43(10):1009-15. PubMed ID: 23859101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low-Density Lipoprotein Cholesterol or Non-High-Density Lipoprotein Cholesterol.
    Sniderman AD; Islam S; McQueen M; Pencina M; Furberg CD; Thanassoulis G; Yusuf S
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27737874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Apolipoprotein (ApoB/ApoA-1) and Lipoprotein (Total Cholesterol/HDL) Ratios in Obese Adolescents.
    Alemzadeh R; Kichler J
    Metab Syndr Relat Disord; 2018 Feb; 16(1):40-45. PubMed ID: 29154726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.
    Rana JS; Visser ME; Arsenault BJ; Després JP; Stroes ES; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
    Int J Cardiol; 2010 Sep; 143(3):399-404. PubMed ID: 19394708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.
    van der Steeg WA; Holme I; Boekholdt SM; Larsen ML; Lindahl C; Stroes ES; Tikkanen MJ; Wareham NJ; Faergeman O; Olsson AG; Pedersen TR; Khaw KT; Kastelein JJ
    J Am Coll Cardiol; 2008 Feb; 51(6):634-42. PubMed ID: 18261682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study.
    Schaefer EJ; Lamon-Fava S; Cohn SD; Schaefer MM; Ordovas JM; Castelli WP; Wilson PW
    J Lipid Res; 1994 May; 35(5):779-92. PubMed ID: 8071601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study.
    Ndumele CE; Matsushita K; Astor B; Virani SS; Mora S; Williams EK; Hoogeveen RC; Blumenthal RS; Sharrett AR; Ballantyne CM; Coresh J
    Eur J Prev Cardiol; 2014 Jul; 21(7):866-75. PubMed ID: 23109406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population.
    Wang TD; Chen WJ; Chien KL; Seh-Yi Su SS; Hsu HC; Chen MF; Liau CS; Lee YT
    Am J Cardiol; 2001 Oct; 88(7):737-43. PubMed ID: 11589839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.
    Cai HJ; Li ZX; Yang SM
    Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.